Single Session Psychotherapy for Depression
(CARED Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a single session of psychotherapy can help adults with moderate depression. Researchers aim to determine if this approach is easy to use and effective in reducing symptoms. Participants will engage in a 3-hour therapy session and complete mental health questionnaires before and after. This trial suits adults diagnosed with major depressive disorder who experience moderate symptoms affecting daily life. As an unphased trial, it offers participants the opportunity to contribute to innovative research that could enhance future treatment options.
Will I have to stop taking my current medications?
If you are taking psychotropic medication, you must be on a stable dose for at least 4 weeks and not plan to change the dose in the next 4 weeks. Otherwise, the trial does not specify if you need to stop other medications.
What prior data suggests that this single session psychotherapy intervention is safe?
Research has shown that single-session psychotherapy, a one-time therapy session, is generally safe for treating depression. Many studies have found positive effects from these sessions. For example, one study reported that 83% of reviews showed benefits for both young people and adults. Another study found that even a single online therapy session effectively reduced depression symptoms in teenagers.
These findings suggest that single-session psychotherapy is well-tolerated and doesn't cause major side effects. Specifically, one study found it safe and practical for reducing the risk of suicide. Overall, the evidence supports single-session therapy as a safe option for helping people with depression.12345Why are researchers excited about this trial?
Researchers are excited about Single Session Psychotherapy for depression because it offers a fast and efficient alternative to traditional therapies, which often require multiple sessions over weeks or months. This approach delivers the entire therapeutic intervention in just one session, potentially reducing the time and cost associated with treatment, making it more accessible for many people. Additionally, it aims to provide immediate support and relief, which could be especially beneficial for those with busy schedules or limited access to ongoing therapy.
What evidence suggests that this single session psychotherapy intervention might be an effective treatment for depression?
Research has shown that just one therapy session can help treat depression. In five out of six studies, people with depression experienced positive results. Another review found that therapy significantly reduced depression symptoms after just one session. Additionally, 83% of reviews reported benefits from single-session therapy for mental health issues. These findings suggest that even one therapy session, such as the Single Session Psychotherapy Intervention tested in this trial, can help reduce depression symptoms in adults.14678
Who Is on the Research Team?
Flavio Frohlich, Ph.D.
Principal Investigator
Univeristy of North Carolina Chapel Hill
Are You a Good Fit for This Trial?
This trial is for adults with moderate to severe depression. Participants must complete a detailed diagnostic interview, mental health questionnaires at the start and two weeks after treatment, and attend a 3-hour single session of psychotherapy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 3-hour, evidence-based, single session psychotherapeutic intervention with a trained clinician
Follow-up
Participants complete mental health questionnaires to assess changes in psychological impairment and other measures
What Are the Treatments Tested in This Trial?
Interventions
- Single Session Psychotherapy Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
The Foundation of Hope for Research and Treatment of Mental Illness
Collaborator